Table 3 Manifestations on chest CT scans of 118 patients at admission and discharge.
The most severe CT manifestations | Discharge CT manifestations | P value | |
|---|---|---|---|
Pulmonary involvement | |||
Number of lung lobes involved | 438 | 329 | 0.000 |
No involvement | 1 (0.8%) | 19 (16.1%) | 0.000 |
Double lung involvement | 100 (84.7%) | 84 (71.2%) | 0.012 |
Right upper lobe | 79 (66.9%) | 56 (47.5%) | 0.002 |
Right middle lobe | 72 (61.0%) | 42 (35.6%) | 0.000 |
Right lower lobe | 99 (83.9%) | 81 (68.6%) | 0.006 |
Left upper lobe | 83 (70.3%) | 64 (54.2%) | 0.011 |
Left lower lobe | 105 (89.0%) | 86 (72.9%) | 0.002 |
Median of the involved lung lobes | 4 (0–5) | 3 (0–5) | 0.000 |
Number of lung segment involvement | 1066 | 600 | 0.000 |
Median of the involved lung segment | 9 (0–20) | 5 (0–20) | 0.000 |
Imaging signs | |||
Main signs | |||
No performance | 1 (0.8%) | 20 (16.9%) | 0.000 |
Ground glass opacities | 37 (31.4%) | 72 (61.0%) | 0.000 |
Ground glass opacities and consolidation | 24 (20.3%) | 12 (10.2%) | 0.030 |
Ground glass opacities and reticular patterns | 38 (32.2%) | 10 (8.5%) | 0.000 |
Mixed type | 16 (13.6%) | 2 (1.7%) | 0.001 |
White lung | 2 (1.7%)※ | 2 (1.7%)※ | 1.000 |
Secondary signs | |||
None | 17 (14.4%) | 44 (37.3%) | 0.000 |
Linear opacities | 66 (55.9%) | 70 (59.3%) | 0.598 |
Bronchograms | 55 (46.6%) | 11 (9.3%) | 0.000 |
Thickness of small blood vessels | 43 (36.4%) | 6 (5.1%) | 0.000 |
Pleural hypertrophy | 16 (13.6%) | 12 (10.2%) | 0.421 |
Nodular shadow | 5 (4.2%) | 4 (3.4%) | 0.734 |
Mediastinal lymph node enlargement | 2 (1.7%) | 0 (0.0%) | 0.156 |
Pleural effusion | 1 (0.8%) | 1 (0.8%) | 1.000 |
PII | 30.0% (0–97.5%) | 12.5% (0–53.0%)Δ | 0.000 |
